Ray Dalio Incyte Corp Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Incyte Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 627,731 shares of INCY stock, worth $44 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

627,731

Previous 671,777 6.56%

Holding current value

$44 Million

Previous $46.4 Million 18.08%

% of portfolio

0.18%

Previous 0.22%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$60.0 - $75.26 $2.64 Million - $3.31 Million	-44,046 Reduced 6.56%	627,731 $38 Million
Q4 2024 Feb 13, 2025	BUY	$65.08 - $83.38 $23.6 Million - $30.3 Million	363,145 Added 117.66%	671,777 $46.4 Million
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $10.4 Million - $12.5 Million	181,504 Added 142.77%	308,632 $20.4 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $12.3 Million - $15.3 Million	-239,484 Reduced 65.32%	127,128 $7.71 Million
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $80,414 - $94,690	-1,422 Reduced 0.39%	366,612 $20.9 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $112,926 - $138,971	-2,165 Reduced 0.58%	368,034 $23.1 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $3.03 Million - $3.46 Million	52,454 Added 16.51%	370,199 $21.4 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $2.51 Million - $3.11 Million	41,234 Added 14.91%	317,745 $19.8 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $356,066 - $436,070	5,070 Added 1.87%	276,511 $20 Million
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $4.89 Million - $6.12 Million	-72,810 Reduced 21.15%	271,441 $21.8 Million
Q3 2022 Nov 10, 2022	SELL	$66.18 - $82.86 $3.09 Million - $3.87 Million	-46,692 Reduced 11.94%	344,251 $22.9 Million
Q2 2022 Aug 11, 2022	BUY	$66.18 - $83.18 $22.5 Million - $28.3 Million	340,133 Added 669.42%	390,943 $29.7 Million
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $1.9 Million - $2.29 Million	28,716 Added 129.97%	50,810 $4.04 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $1.02 Million - $1.19 Million	16,047 Added 265.37%	22,094 $1.62 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $1.52 Million - $1.87 Million	-22,201 Reduced 78.59%	6,047 $416,000
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $2.26 Million - $2.47 Million	28,248 New	28,248 $2.38 Million

Others Institutions Holding INCY

# of Institutions

695

Shares Held

194M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account